-
Mashup Score: 4Best Practices for Active Surveillance - Benjamin Lowentritt, Ronney Abaza, Aaron Berger, David Crawford, & David Morris - 2 month(s) ago
Benjamin Lowentritt leads a panel discussion on active surveillance for prostate cancer, with a focus on appropriate patient selection, adherence monitoring, and determining triggers to stop surveillance and pursue treatment. The experts emphasize that most low risk patients should be offered active surveillance and monitored closely, though debate exists around including favorable intermediate…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4Best Practices for Active Surveillance - Benjamin Lowentritt, Ronney Abaza, Aaron Berger, David Crawford, & David Morris - 3 month(s) ago
Benjamin Lowentritt leads a panel discussion on active surveillance for prostate cancer, with a focus on appropriate patient selection, adherence monitoring, and determining triggers to stop surveillance and pursue treatment. The experts emphasize that most low risk patients should be offered active surveillance and monitored closely, though debate exists around including favorable intermediate…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Best practices for #ActiveSurveillance. @UroDrBen, @DrRonneyAbaza, Aaron Berger, @DavidCrawfordMD, & David Morris discuss appropriate patient selection, adherence monitoring, and determining triggers to stop surveillance and pursue treatment > https://t.co/RdMyWox0to @UrologyUS https://t.co/PE0LBN4kZ9
-
-
Mashup Score: 4Best Practices for Active Surveillance - Benjamin Lowentritt, Ronney Abaza, Aaron Berger, David Crawford, & David Morris - 4 month(s) ago
Benjamin Lowentritt leads a panel discussion on active surveillance for prostate cancer, with a focus on appropriate patient selection, adherence monitoring, and determining triggers to stop surveillance and pursue treatment. The experts emphasize that most low risk patients should be offered active surveillance and monitored closely, though debate exists around including favorable intermediate…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Best practices for #ActiveSurveillance. @UroDrBen, @DrRonneyAbaza, Aaron Berger, @DavidCrawfordMD, & David Morris discuss appropriate patient selection, adherence monitoring, and determining triggers to stop surveillance and pursue treatment > https://t.co/RdMyWox0to @UrologyUS https://t.co/PE0LBN4kZ9
-
-
Mashup Score: 0Prostate Cancer Clinical Trial: ESCAPE Trial - 10 month(s) ago
This is “Prostate Cancer Clinical Trial: ESCAPE Trial” by PRIMR on Vimeo, the home for high quality videos and the people who love them.
Source: VimeoCategories: Hem/Oncs, Latest HeadlinesTweet-
ESCAPE will test #PSMA in men on #ActiveSurveillance. Looking forward to multi-site collaboration. @WeillCornell @UCLAJCCC @UCSFCancer @UTSWNews @UHhospitals @TimMcClureMD @dr_coops @RobertReiterMD @wayne_brisbane @jeshoag @DrWoldu @PRIMR_MED @LantheusNews https://t.co/lbBBCgItnO
-
-
Mashup Score: 0Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study - 11 month(s) ago
Background: Although a few studies have reported wide variations in quality of care in active surveillance (AS), there is a lack of research using validated quality indicators (QIs). The aim of this study was to apply evidence-based QIs to examine the quality of AS care at the population level. Methods: QIs were measured using a population-based retrospective cohort of patients with low-risk…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Applying Quality Indicators to Examine Quality of Care During #ActiveSurveillance in Low-Risk #ProstateCancer: A Population-Based Study: https://t.co/pkpIQY3cR6 #PCSM #hsronc @NarhariT @UroOncMD @BeateSander @ihpmeuoft https://t.co/kNrNwxRqdQ
-
-
Mashup Score: 0
Active surveillance is not inferior to primary intervention for patients with small renal masses suspicious for RCC, according to new research.
Source: GU Oncology NowCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New research presented at #AUA23 based on a 12-year prospective comparative study showed that #activesurveillance is not inferior to primary intervention for patients with small renal masses suspicious for renal cell carcinoma. Learn more: https://t.co/EPHzOWJ1nT https://t.co/8mFuOExUgU
-
-
Mashup Score: 0
Active surveillance (AS), Prostate Cancer (PC), intraductal carcinoma, IDC-P, cribriform, radical prostatectomy, low-risk prostate cancer (PC), factor of IDC-P or cribriform patterns in radical prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for #ActiveSurveillance: data from the PRIAS-JAPAN study. #BeyondTheAbstract on UroToday > https://t.co/1iAjaLlRxl @TohiYoichiro https://t.co/ieIpXz355V
-
-
Mashup Score: 0More men with prostate cancer opting for active surveillance - 1 year(s) ago
Use of active surveillance for low-risk and favorable intermediate-risk prostate cancer increased sharply in the United States during the past decade, according to data published in JAMA Internal Medicine. Nearly 60% of men in the U.S. with low-risk disease chose active surveillance in 2018, up from 16.4% in 2010. However, the rate still lags those of Sweden (74% by 2014) and Australia (67% by
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fox Chase's Dr. Marc Smaldone (@FCUroOnc) provided perspective to a @GoHealio article on #ProstateCancer and #ActiveSurveillance: https://t.co/RQTUEG5QzV
-
-
Mashup Score: 1Active Surveillance vs Definitive Treatment in Low- and Favorable Intermediate–Risk Prostate Cancer - 1 year(s) ago
This cross-sectional study of data from the Surveillance, Epidemiology and End Results database assesses temporal trends in the use of active surveillance and watchful waiting vs definitive treatment in men with low- and favorable intermediate–risk prostate cancer in the US between 2010 and 2018.
Source: jamanetwork.comCategories: General Medicine News, Latest HeadlinesTweet-
More US #prostatecancer patients choosing #activesurveillance over surgery or radiation @JAMAInternalMed https://t.co/teaajfvUKH https://t.co/tx58Du3JJB
-
-
Mashup Score: 3
Active surveillance (AS), Prostate Cancer (PC), intraductal carcinoma, IDC-P, cribriform, radical prostatectomy, low-risk prostate cancer (PC), factor of IDC-P or cribriform patterns in radical prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for #ActiveSurveillance: data from the PRIAS-JAPAN study. #BeyondTheAbstract on UroToday > https://t.co/1iAjaLlRxl @TohiYoichiro https://t.co/jGIboQU2yC
-
Best practices for #ActiveSurveillance. @UroDrBen, @DrRonneyAbaza, Aaron Berger, @DavidCrawfordMD, & David Morris discuss appropriate patient selection, adherence monitoring, and determining triggers to stop surveillance and pursue treatment > https://t.co/RdMyWox0to @UrologyUS https://t.co/PE0LBN4kZ9